Johnson & Johnson

JNJ

New York Stock Exchange. Currency in USD

175.48 -0.19 ( -0.11% )

Real time prices: December 19

Market Cap.
458.79B
Beta (5Y monthly)
0.57
Price/Earnings
17.83
EPS (TTM)
9.94
Forward Dividend
4.52 (2.51%)
Ex-Dividend Date
Nov 22, 2022
Volume
5.52M
1y Target Est.
184.75
Day's Range
174.07
-
176.16
52 Week's Range
155.72
-
186.69

Historical Summary

Performance
EPS growth
Share Buybacks

About Johnson & Johnson

Sector
Healthcare
Industry
Drug Manufacturers-General
Website
https://www.jnj.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
2.63B
Employees
141700
Address
One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Latest news

Wall Street Breakfast: What Moved Markets
Wall Street Breakfast: What Moved Markets

Listen on the go! A daily podcast of Wall Street Breakfast will be available this...
By Seeking Alpha - 6 weeks ago

FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA

The FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for Lynparza's...
By Zacks Investment Research - 7 weeks ago

Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait

These companies will work hard to grow your base of passive income.
By The Motley Fool - 7 weeks ago

Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?

There's a lot more ahead for these market giants.
By The Motley Fool - 7 weeks ago

5 Phenomenal Stocks in Warren Buffett's Secret Portfolio That Are Screaming Buys in 2023
5 Phenomenal Stocks in Warren Buffett's Secret Portfolio That Are Screaming Buys in 2023

The Oracle of Omaha's $5.9 billion hidden portfolio is home to five amazing companies that...
By The Motley Fool - 7 weeks ago

Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca
Zacks Industry Outlook Highlights Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca

Johnson & Johnson, Novo Nordisk, Merck and AstraZeneca have been highlighted in this Industry Outlook...
By Zacks Investment Research - 7 weeks ago

4 Large Drug Stocks to Watch in a Booming Industry
4 Large Drug Stocks to Watch in a Booming Industry

Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap...
By Zacks Investment Research - 7 weeks ago

2 Top Dividend Kings to Buy for the Long Haul
2 Top Dividend Kings to Buy for the Long Haul

No matter how much changes, these two healthcare giants keep performing.
By The Motley Fool - 7 weeks ago